|
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
2.45e-32 |
0.32
|
| BRS3_RAT |
Brs3 |
Bombesin receptor subtype-3 |
1.945e-21 |
0.31
|
| NOD1_HUMAN |
NOD1 |
Nucleotide-binding oligomerization domain-containing protein 1 |
6.295e-14 |
0.31
|
| NEUR3_HUMAN |
NEU3 |
Sialidase-3 |
3.739e-12 |
0.30
|
| ANO1_HUMAN |
ANO1 |
Anoctamin-1 |
2.979e-11 |
0.29
|
| ANO2_HUMAN |
ANO2 |
Anoctamin-2 |
1.479e-10 |
0.28
|
| NOD2_HUMAN |
NOD2 |
Nucleotide-binding oligomerization domain-containing protein 2 |
3.696e-10 |
0.31
|
| S100B_HUMAN |
S100B |
Protein S100-B |
1.012e-09 |
0.28
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
8.463e-07 |
0.31
|
| NPFF2_HUMAN |
NPFFR2 |
Neuropeptide FF receptor 2 |
1.012e-06 |
0.29
|
| PTPRA_HUMAN |
PTPRA |
Receptor-type tyrosine-protein phosphatase alpha |
1.366e-06 |
0.37
|
| SGMR2_HUMAN |
TMEM97 |
Sigma intracellular receptor 2 |
1.688e-06 |
0.29
|
| APEX1_HUMAN |
APEX1 |
DNA-(apurinic or apyrimidinic site) lyase |
1.804e-06 |
0.30
|
| DRD4_RAT |
Drd4 |
D(4) dopamine receptor |
3.848e-06 |
0.30
|
| BRS3_HUMAN |
BRS3 |
Bombesin receptor subtype-3 |
5.578e-06 |
0.31
|